VOYA Investment Management
RUBY

VOYA Investment Management’s Rubius Therapeutics, Inc RUBY Stock Holding History

VOYA Investment Management’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,095
Closed -$100K – 2947
2022
Q1 		$100K Hold
18,095
– – ﹤0.01% 2514
2021
Q4 		$175K Buy
18,095
+287
+2% +$3.98K ﹤0.01% 2557
2021
Q3 		$318K Hold
17,808
– – ﹤0.01% 2308
2021
Q2 		$435K Buy
17,808
+2,184
+14% +$54.6K ﹤0.01% 2176
2021
Q1 		$414K Buy
15,624
+315
+2% +$4.6K ﹤0.01% 2136
2020
Q4 		$116K Buy
15,309
+2,144
+16% +$12.7K ﹤0.01% 2532
2020
Q3 		$66K Hold
13,165
– – ﹤0.01% 2403
2020
Q2 		$79K Sell
13,165
-4,045
-24% -$23.9K ﹤0.01% 2371
2020
Q1 		$77K Hold
17,210
– – ﹤0.01% 2408
2019
Q4 		$163K Buy
17,210
+2,801
+19% +$27.1K ﹤0.01% 2443
2019
Q3 		$113K Hold
14,409
– – ﹤0.01% 2381
2019
Q2 		$227K Buy
14,409
+912
+7% +$14.7K ﹤0.01% 2236
2019
Q1 		$244K Buy
+13,497
New +$207K ﹤0.01% 2164

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VOYA Investment Management's RUBY Position: Q2 2022 in Review

VOYA Investment Management sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 18,095 shares — an estimated $100K sold.

VOYA Investment Management first reported a position in RUBY in Q1 2019 and held it in 13 quarters. The position peaked at $435K in Q2 2021. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

  • VOYA Investment Management reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
  • VOYA Investment Management sold 18,095 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $100K.
  • VOYA Investment Management first reported a position in Rubius Therapeutics, Inc in Q1 2019 and held it in 13 quarters.
  • VOYA Investment Management's Rubius Therapeutics, Inc position peaked at $435K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.